Ar Asset Management Inc Organon & Co. Transaction History

Ar Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$21.42 - $32.08 $781,830 - $1.17 Million	36,500 Added 49.69%	109,955 $2.59 Million
Q4 2022 Feb 01, 2023	SELL	$23.31 - $28.61 $850,815 - $1.04 Million	-36,500 Reduced 33.2%	73,455 $2.05 Million
Q2 2022 Aug 03, 2022	BUY	$31.66 - $38.9 $294,438 - $361,770	9,300 Added 9.24%	109,955 $3.71 Million
Q4 2021 Feb 07, 2022	BUY	$28.67 - $37.13 $2.5 Million - $3.24 Million	87,202 Added 648.2%	100,655 $3.07 Million
Q3 2021 Nov 04, 2021	SELL	$28.63 - $35.64 $286 - $356	-10 Reduced 0.07%	13,453 $441,000
Q2 2021 Aug 04, 2021	BUY	$28.45 - $38.0 $383,022 - $511,594	13,463 New	13,463 $407,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ar Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Ar Asset Management Inc with notifications on news.